Multi-domain non-pharmacological interventions

Multi-domain non-pharmacological interventions has been studied in 1 paper since 2023: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Aug 23, 2023: “Alzheimer's disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges”.

Intervention

1 paper studies it2 findingsUpdated

What did studies of Multi-domain non-pharmacological interventions find?

2

Studies of Multi-domain non-pharmacological interventions measured 2 outcomes; the most studied are disability (1 study) and cognitive function (1).

Disability

downin humans1

1 study
  1. Multi-domain non-pharmacological interventions decrease disability in humans.

    “Notably, multi-domain non-pharmacological interventions wield considerable potential in enhancing cognition and mitigating disability.”

    ReviewAD coupled with frailty

    Alzheimer's disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges

    Bioscience trends

Cognitive function

upin humans1

1 study
  1. Multi-domain non-pharmacological interventions improve cognitive function in humans.

    “Notably, multi-domain non-pharmacological interventions wield considerable potential in enhancing cognition and mitigating disability.”

    ReviewAD coupled with frailty

    Alzheimer's disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges

    Bioscience trends

Latest